STAT3 and Hepatic fibrosis: Administration of AAV8-PGC-1α or TSA to increase PGC-1α mitigated the I/R-promoted M2-type macrophage polarization by inhibiting the IL-6/STAT3 signaling, and alleviating liver fibrosis in I/R mice.